Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients
NCT04371822 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 56
Last updated 2020-06-24
Summary
Efficacy of Sunlight Activated Synthetic Porphyrin in COVID-19 Infected Patients (SnPPIX)
Mahmoud ELkazzaz(1),Rokia yousry abdelaziz sallam(2)
\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_
Abstract :
The novel coronavirus pneumonia (COVID-19) is an infectious acute respiratory caused by the novel coronavirus. The virus is a positive-strand RNA virus with high homology to bat coronavirus. Depending on published study in which , conserved domain analysis, homology modeling, and molecular docking were used to compare the biological roles of specific proteins of the novel coronavirus. The principal investigator demonstrated according to previous researches that some viral structural and nonstructural proteins could bind to the porphyrin, respectively. At the same time, orf1ab, ORF10 and ORF3a proteins coordinated to attack heme on the 1-beta chain of hemoglobin, COVID-19 binds to the porphyrin of haem and displaces iron and a study denonestrated that Covid-19 could cause acquired acute porphyria which is the condition in which there is excess accumulation of porphyrin intermediate metabolites. This point can be taken advantage of X-ray induced visible luminescence of porphyrin for producing of Reactive Oxygen Species (ROS).Many porphyrins are benign in the dark but are transformed by sunlight into caustic, flesh-eating toxins Porphyrins have been used for photodynamic therapy (PDT) against a wide range of targets like bacteria, viruses and tumor cells It has been reported that ROS-based inactivation of viruses may occur due to several reasons, such as protein oxidation, single strand breaks in the RNA genome and protein-RNA crosslinking. Since ROS-based inactivation has a multi-targeted mechanism, it is much less likely that a virus would be able to develop resistance against it. Recently, porphyrins, already in use as photosensitizers for Photodynamic Therapy (PDT), were a study target to applications in medical area, namely as possible contrast agents in MRI. could be observed some examples of porphyrin derivatives already study as MRI contrast media. Low dark toxicity, neoplastic tissue affinity and synthetic accessibility are some of the important properties that contribute for its selection. In MRI studies was found that CM based on paramagnetic metalloporphyrins showed higher affinity for neoplastic tissues, observed by increased relaxation time of the neoplastic tissues, which is reflected on an increase in MRI signal and consequently in a better neoplastic lesions detection. A study demonestrated that The sulfonated tetranaphthyl porphyrin contrast agents in MRI (TNapPS), sulfonated tetra-anthracenyl porphyrin (TAnthPS), and sulfonated 2,6-difluoro-meso-tetraphenylporphine \[TPP(2,6-F2)S\] and its copper chelate \[TPP(2,6-F2)S,Cu\], which reduced HIV infection by 99, 96, 94, and 96%, respectively. Previous studies which showed that Covid -19 binds to the porphyrin of haem and displaces iron in addition to Sulfonated porphyrins and light-stimulated Sn- protoporphyrin IX have broad antiviral activity against more distinct types of viruses, Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope Porphyrins are amphipathic molecules able to interact with membranes and absorb light, being widely used in photodynamic therapy. Previously, we showed that heme, Co-protoporphyrin IX (CoPPIX) and Sn-protoporphyrin IX (SnPPIX) directly inactivate DENV and YFV infectious particles. Here we demonstrate that the antiviral activity of these porphyrins can be broadened to CHIKV, ZIKV, Mayaro virus, Sindb is virus and Vesicular Stomatitis virus. Porphyrin treatment causes viral envelope protein loss, affecting viral morphology, adsorption and entry into target cells , Finally, the principal investigator expect that viral load will be declined with sunlight because In particular, porphyrins absorb essentially all the UV/visible light wavelengths in the emission spectrum of the sun; hence they are active at very low doses .
Keywords: COVID 2019 ,Infection, Sulfonated porphyrins and X-ray induced visible luminescence of porphyrin
Conditions
Interventions
- DRUG
-
SnPP Protoporphyrin plus Sunlight exposure
SnPP Protoporphyrin plus Sunlight exposure
- DRUG
-
SnPP Protoporphyrin plus Sunlight exposure
SnPP Protoporphyrin and Sunlight exposure
- DRUG
-
SnPP Protoporphyrin plus Sunlight exposure
SnPP Protoporphyrin plus Sunlight exposure
- DRUG
-
Sulfonatoporphyrin(TPPS) plus Sunlight exposure.
Sulfonatoporphyrin(TPPS) plus Sunlight exposure.
- OTHER
-
placebo
No Intervention
Sponsors & Collaborators
-
Kafrelsheikh University
lead OTHER
Principal Investigators
-
M.Sc. Mahmoud Elkazzaz, M.Sc.in Biochemistry · Damitta University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-08-31
- Primary Completion
- 2020-10-31
- Completion
- 2020-11-30
Countries
- Egypt
More Related Trials
-
Excimer Light in Psoriasis
NCT05283876 ·Status: COMPLETED ·Phase: NA
-
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
NCT06144840 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of COVID 19 on Psoriasis Patients
NCT05381402 ·Status: UNKNOWN
-
Treatment of Oral Lichen Planus With Paeoniflorin and Photodynamic Therapy
NCT05973097 ·Status: RECRUITING ·Phase: NA
-
Studying the Effect of Methotrexate Alone Versus Methotrexate and Vitamin D on the Cardiovascular Risk of Psoriatic Patients
NCT03904680 ·Status: UNKNOWN ·Phase: PHASE4
-
Methotrexate Alone vs Combination With Excimer Light in Nail Psoriasis
NCT06150794 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Cardiovascular Risk Evaluation in Psoriasis Treated With Photochemotherapy
NCT02990624 ·Status: COMPLETED ·Phase: NA
-
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
NCT01230138 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Purslane in Treatment of Oral Lichen Planus
NCT00746772 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum TWEAK Level in Psoriasis
NCT04811911 ·Status: UNKNOWN ·Phase: PHASE4
-
Adjunctive Oral Systemic Vitamin E Therapy on Salivary Nitric Oxide Level in Patients With Erosive Oral Lichen Planus
NCT05787925 ·Status: COMPLETED ·Phase: NA
-
Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP
NCT05401201 ·Status: COMPLETED ·Phase: NA
-
To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
NCT04566666 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Efficacy of Topical Curcumin in Treatment of Oral Lichen Planus
NCT06605911 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Topical ALT-2074 (SYI-2074) for Treatment of Chronic Plaque Psoriasis
NCT00782613 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis
NCT02618616 ·Status: COMPLETED ·Phase: PHASE2
-
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis
NCT03431974 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Two Algae Formulations on Lipid Metabolism, Inflammation and Oxidative Stress Status in Individuals With Psoriasis
NCT01045395 ·Status: COMPLETED ·Phase: PHASE1
-
Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus
NCT01375101 ·Status: UNKNOWN ·Phase: PHASE1
-
Different Treatment Modalities for Oral Lichen Plan
NCT06681090 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis
NCT02785172 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Topical Curcumin Versus Topical Corticosteroid on Management of Oral Lichen Planus Patients
NCT03877679 ·Status: UNKNOWN ·Phase: PHASE1
-
Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol
NCT00678756 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety and Efficacy of BFH772 in Psoriasis Patients
NCT00987870 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Open-label, Non-controlled Study of KHK4827 in Subjects With Psoriasis
NCT01782937 ·Status: COMPLETED ·Phase: PHASE3